9 articles
Vendor management best practices in clinical trials: proportionate oversight and clear roles. Fix the common failures, from missing plans to unread KPIs.
The clinical trial vendor management plan and SOP do different jobs — and inspectors expect both. What each document must contain, and how the two fit together.
Types of clinical trial vendors, and how to match oversight to each: the vendor type sets what is at risk, so sort by potential harm, not by spend.
CRO oversight in clinical trials: the CRO is the one vendor you can transfer regulatory obligations to in writing. Everything else stays with you.
Vendor performance metrics in clinical trials should trigger decisions: KPIs tied to thresholds and actions, built from the data vendors touch.
Vendor qualification in clinical trials proves with evidence that a provider meets your standards — tiered to the risk each vendor actually carries.
Clinical trial vendor selection is the first act of oversight: choose for capability, not price, and build the evidence an inspector later reads.
Vendor oversight in clinical trials is a documented, risk-based system that stays with the sponsor even when the work is transferred to a CRO or vendor.
Vendor management in clinical trials keeps sponsor accountability for outsourced work — a proportionate, risk-based oversight system under ICH E6(R3).
